Let me see where we will be this time around next year:
shareprice now $ 11
uplisting +$10 2 (out of 4) new drugs 2x +$2.50 = +$5 acquisition of a new drug or even a complete company +$2.50 a few new TCM's from Hongrui's line up +$2.50
That all ads up to: $31.00
Remarks on my calcultion are welcome, just trying to evaluate where we are and where we reasonably could be next year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.